Deletion(20q) as the sole abnormality in plasma cell myeloma is not associated with plasma cells as identified by cIg FISH

Cancer Genetics - Tập 205 - Trang 644-652 - 2012
Joanne S. White1, Adrian Zordan1, Crisoula Batzios1, Lynda J. Campbell1,2
1Victorian Cancer Cytogenetics Service, St Vincent's Hospital (Melbourne), Fitzroy, Australia
2University of Melbourne, Department of Medicine, St. Vincent's Hospital Melbourne, Fitzroy, Australia

Tài liệu tham khảo

2008

Rajkumar, 2009, Multiple myeloma, Curr Probl Cancer, 33, 7, 10.1016/j.currproblcancer.2009.01.001

Fonseca, 2004, Genetics and cytogenetics of multiple myeloma: a workshop report, Cancer Res, 64, 1546, 10.1158/0008-5472.CAN-03-2876

Avet-Loiseau, 2007, Role of genetics in prognostication in myeloma, Best Pract Res Clin Haematol, 20, 625, 10.1016/j.beha.2007.08.005

Sawyer, 2011, The prognostic significance of cytogenetics and molecular profiling in multiple myeloma, Cancer Genet, 204, 3, 10.1016/j.cancergencyto.2010.11.002

Debes-Marun, 2003, Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma, Leukemia, 17, 427, 10.1038/sj.leu.2402797

Jacobson, 2003, MDS-type abnormalities within myeloma signature karyotype (MM-MDS): only 13% 1-year survival despite tandem transplants, Br J Haematol, 122, 430, 10.1046/j.1365-2141.2003.04455.x

Schmetzer, 1998, Development of myeloma and secondary myelodysplastic syndrome from a common clone, Cancer Genet Cytogenet, 100, 31, 10.1016/S0165-4608(97)00002-2

Březinová, 2005, Prognostic significance of del(20q) in patients with hematological malignancies, Cancer Genet Cytogenet, 160, 188, 10.1016/j.cancergencyto.2004.12.019

Liu, 2006, Deletion (20q) as the sole abnormality in Waldenström macroglobulinemia suggests distinct pathogenesis of 20q11 anomaly, Cancer Genet Cytogenet, 169, 69, 10.1016/j.cancergencyto.2006.03.013

Barlogie, 2008, Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989, Blood, 111, 94, 10.1182/blood-2007-06-097444

Slovak, 2005, Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization, Cancer Genet Cytogenet, 158, 99, 10.1016/j.cancergencyto.2005.01.006

Nilsson, 2004, MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q), Genes Chromosomes Cancer, 41, 223, 10.1002/gcc.20078

Crescenzi, 2009, Totipotent stem cells bearing del(20q) maintain multipotential differentiation in Shwachman Diamond syndrome, Br J Haematol, 144, 116, 10.1111/j.1365-2141.2008.07448.x

White, 1994, Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells, Blood, 83, 2809, 10.1182/blood.V83.10.2809.2809

Steensma, 2003, The myelodysplastic syndrome(s): a perspective and review highlighting current controversies, Leuk Res, 27, 95, 10.1016/S0145-2126(02)00098-X

Steensma, 2003, Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia?, Leuk Res, 27, 235, 10.1016/S0145-2126(02)00161-3

Campbell, 2011, Cytogenetic analysis in acute myeloid leukaemia, 63

2009

Mercer, 2011, Detection of chromosome abnormalities using cytoplasmic immunoglobulin staining and FISH in myeloma, 159

Ross, 2012, Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders, Haematologica, 97, 1272, 10.3324/haematol.2011.056176

Garayoa, 2009, Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors, Leukemia, 23, 1515, 10.1038/leu.2009.65

Arnulf, 2007, Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma, Leukemia, 21, 158, 10.1038/sj.leu.2404466

Streubel, 2004, Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas, N Engl J Med, 351, 250, 10.1056/NEJMoa033153

Sahota, 2006, Lineage complexity in multiple myeloma?, Leuk Lymphoma, 47, 1997, 10.1080/10428190600758686

Rigolin, 2006, Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion, Blood, 107, 2531, 10.1182/blood-2005-04-1768

Ghosh, 2009, Cancer stem cells in multiple myeloma, Cancer Lett, 277, 1, 10.1016/j.canlet.2008.08.005

Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013

Thông tin
Thông tin xuất bản

Cancer Genetics

Tập 205

644-652

Thông tin tác giả